SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 27th, 2024 • Vigil Neuroscience, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 27, 2024, by and between Vigil Neuroscience, Inc., a Delaware corporation (the “Company”), and Aventis Inc., a company organized and existing under the laws of the State of Pennsylvania, having registered offices at 55 Corporate Drive in Bridgewater, New Jersey 08807 (the “Purchaser”).
